HANGZHOU TIGERMED CO. H 1HANGZHOU TIGERMED CO. H 1HANGZHOU TIGERMED CO. H 1

HANGZHOU TIGERMED CO. H 1

No trades
Buy 5HZ1

5HZ1 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

5HZ1 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company